Tirzepatide CAS 2023788-19-2

CAS No:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813.45
EINECS NO:200-001-8

Application:Tirzepatide has a similar sequence to semaglutide. The lys side chain in the sequence is modified with PEG, which is a functional group of the polypeptide and can increase the water solubility of the sequence.The main physiological function of Tirzepa Chemicalbooktide is a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is being developed for the treatment of type 2 diabetes and has entered the clinical stage.

Tirzepatide CAS 2023788-19-2

Semaglutide CAS 910463-68-2

Retatrutide CAS 2381089-83-2

Liaglutide CAS 204656-20-2

Whatsapp/Telegram:+86 13363081709

[email protected]

Retatrutide（LY3437943）5MG 10MG 15MG 20MG Weight Loss Peptide

Common Name LY3437943

CAS Number 2381089-83-2

Molecular Weight 4731.33

Molecular Formula C221H342N46O68

LY3437943 can be used for the research of obesity.

Tirzepatide CAS 2023788-19-2

Semaglutide CAS 910463-68-2

Retatrutide CAS 2381089-83-2

Liaglutide CAS 204656-20-2

Whatsapp/Telegram:+86 13363081709

[email protected]

CAS No. 910463-68-2

Chemical Name: Semaglutide

Synonyms：

semaglutide;Semaglutide impurity;Sermaglutide USP/EP/BP;Sermaglutide CAS 910463 68 2;OG217SC;Ozempic;Somaroutin;semgalutide;Somaglutide;Somarlutide

Molecular Formula: C187H291N45O59

Molecular Weight: 4113.57754

Description

Semaglutide(910463-68-2) is an anti-diabetic medication that is sold under brand names such as Ozempic, Wegovy, and Rybelsus. It is used to treat type 2 diabetes and manage chronic weight. The drug functions similar to human glucagon-like peptide-1 (GLP-1) by increasing insulin secretion, which leads to improved sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen, or as an oral form. One of its advantages over other antidiabetic drugs is that it has a long duration of action, thus, only once-a-week injection is sufficient.

Uses

Semaglutide is used to manage type 2 diabetes along with lifestyle changes, such as dietary restrictions and increased physical activity. It also works by slowing the movement of food through the stomach and may decrease appetite and cause weight loss. There have been no published reports of hepatotoxicity attributed to semaglutide therapy.

109555-87-5  3-(1-Naphthoyl)indole

1119-51-3  5-Bromo-1-pentene

WhatsApp: +852 46209514
Telegram: @Vevi21
Signal: Tara.369
Threema: E4V7WXT6